Logo image of NWH-DB-H.CA

NORTHWEST HEALTHCARE PRO (NWH-DB-H.CA) Stock Price, Forecast & Analysis

Canada - Toronto Stock Exchange - TSX:NWH-DB-H - CA667495AJ41

101.9 CAD
+0.47 (+0.46%)
Last: 12/18/2025, 7:00:00 PM
Fundamental Rating

3

Overall NWH-DB-H gets a fundamental rating of 3 out of 10. We evaluated NWH-DB-H against 38 industry peers in the Diversified REITs industry. There are concerns on the financial health of NWH-DB-H while its profitability can be described as average. NWH-DB-H has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

NWH-DB-H had positive earnings in the past year.
In the past year NWH-DB-H had a positive cash flow from operations.
In multiple years NWH-DB-H reported negative net income over the last 5 years.
Each year in the past 5 years NWH-DB-H had a positive operating cash flow.
NWH-DB-H.CA Yearly Net Income VS EBIT VS OCF VS FCFNWH-DB-H.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

The Return On Assets of NWH-DB-H (0.82%) is comparable to the rest of the industry.
NWH-DB-H has a Return On Equity (3.06%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 3.41%, NWH-DB-H is doing worse than 65.79% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for NWH-DB-H is below the industry average of 5.49%.
The 3 year average ROIC (3.39%) for NWH-DB-H is below the current ROIC(3.41%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.82%
ROE 3.06%
ROIC 3.41%
ROA(3y)-2.92%
ROA(5y)0.56%
ROE(3y)-11.33%
ROE(5y)0.68%
ROIC(3y)3.39%
ROIC(5y)3.39%
NWH-DB-H.CA Yearly ROA, ROE, ROICNWH-DB-H.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

NWH-DB-H's Profit Margin of 11.90% is in line compared to the rest of the industry. NWH-DB-H outperforms 55.26% of its industry peers.
NWH-DB-H has a Operating Margin of 61.05%. This is in the better half of the industry: NWH-DB-H outperforms 78.95% of its industry peers.
In the last couple of years the Operating Margin of NWH-DB-H has declined.
NWH-DB-H has a better Gross Margin (74.32%) than 84.21% of its industry peers.
In the last couple of years the Gross Margin of NWH-DB-H has remained more or less at the same level.
Industry RankSector Rank
OM 61.05%
PM (TTM) 11.9%
GM 74.32%
OM growth 3Y-1.83%
OM growth 5Y-2.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.75%
GM growth 5Y-0.16%
NWH-DB-H.CA Yearly Profit, Operating, Gross MarginsNWH-DB-H.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

2

2. Health

2.1 Basic Checks

NWH-DB-H has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, NWH-DB-H has more shares outstanding
The number of shares outstanding for NWH-DB-H has been increased compared to 5 years ago.
NWH-DB-H has a better debt/assets ratio than last year.
NWH-DB-H.CA Yearly Shares OutstandingNWH-DB-H.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
NWH-DB-H.CA Yearly Total Debt VS Total AssetsNWH-DB-H.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

NWH-DB-H has an Altman-Z score of 3.40. This indicates that NWH-DB-H is financially healthy and has little risk of bankruptcy at the moment.
NWH-DB-H has a Altman-Z score of 3.40. This is amongst the best in the industry. NWH-DB-H outperforms 92.11% of its industry peers.
The Debt to FCF ratio of NWH-DB-H is 24.51, which is on the high side as it means it would take NWH-DB-H, 24.51 years of fcf income to pay off all of its debts.
NWH-DB-H has a Debt to FCF ratio of 24.51. This is in the lower half of the industry: NWH-DB-H underperforms 65.79% of its industry peers.
A Debt/Equity ratio of 1.47 is on the high side and indicates that NWH-DB-H has dependencies on debt financing.
NWH-DB-H's Debt to Equity ratio of 1.47 is on the low side compared to the rest of the industry. NWH-DB-H is outperformed by 65.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF 24.51
Altman-Z 3.4
ROIC/WACC0.47
WACC7.31%
NWH-DB-H.CA Yearly LT Debt VS Equity VS FCFNWH-DB-H.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

NWH-DB-H has a Current Ratio of 0.16. This is a bad value and indicates that NWH-DB-H is not financially healthy enough and could expect problems in meeting its short term obligations.
NWH-DB-H has a worse Current ratio (0.16) than 63.16% of its industry peers.
A Quick Ratio of 0.16 indicates that NWH-DB-H may have some problems paying its short term obligations.
NWH-DB-H's Quick ratio of 0.16 is on the low side compared to the rest of the industry. NWH-DB-H is outperformed by 63.16% of its industry peers.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.16
NWH-DB-H.CA Yearly Current Assets VS Current LiabilitesNWH-DB-H.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 109.98% over the past year.
The Revenue for NWH-DB-H has decreased by -32.34% in the past year. This is quite bad
Measured over the past years, NWH-DB-H shows a small growth in Revenue. The Revenue has been growing by 4.78% on average per year.
EPS 1Y (TTM)109.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.53%
Revenue 1Y (TTM)-32.34%
Revenue growth 3Y7.27%
Revenue growth 5Y4.78%
Sales Q2Q%-2.55%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NWH-DB-H.CA Yearly Revenue VS EstimatesNWH-DB-H.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
NWH-DB-H.CA Yearly EPS VS EstimatesNWH-DB-H.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.5 1 1.5

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 509.50 indicates a quite expensive valuation of NWH-DB-H.
Compared to the rest of the industry, the Price/Earnings ratio of NWH-DB-H is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 26.26. NWH-DB-H is valued rather expensively when compared to this.
Industry RankSector Rank
PE 509.5
Fwd PE N/A
NWH-DB-H.CA Price Earnings VS Forward Price EarningsNWH-DB-H.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as NWH-DB-H.
NWH-DB-H's Price/Free Cash Flow ratio is rather expensive when compared to the industry. NWH-DB-H is more expensive than 89.47% of the companies in the same industry.
Industry RankSector Rank
P/FCF 214.55
EV/EBITDA 110.08
NWH-DB-H.CA Per share dataNWH-DB-H.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

NWH-DB-H has a Yearly Dividend Yield of 10.04%, which is a nice return.
NWH-DB-H's Dividend Yield is rather good when compared to the industry average which is at 7.11. NWH-DB-H pays more dividend than 92.11% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, NWH-DB-H pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.04%

5.2 History

The dividend of NWH-DB-H decreases each year by -13.72%.
NWH-DB-H does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)-13.72%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

154.63% of the earnings are spent on dividend by NWH-DB-H. This is not a sustainable payout ratio.
DP154.63%
EPS Next 2YN/A
EPS Next 3YN/A
NWH-DB-H.CA Yearly Income VS Free CF VS DividendNWH-DB-H.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
NWH-DB-H.CA Dividend Payout.NWH-DB-H.CA Dividend Payout, showing the Payout Ratio.NWH-DB-H.CA Dividend Payout.PayoutRetained Earnings

NORTHWEST HEALTHCARE PRO

TSX:NWH-DB-H (12/18/2025, 7:00:00 PM)

101.9

+0.47 (+0.46%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-11 2025-11-11
Earnings (Next)03-09 2026-03-09
Inst Owners10.93%
Inst Owner ChangeN/A
Ins Owners0.39%
Ins Owner ChangeN/A
Market Cap25.47B
Revenue(TTM)417.64M
Net Income(TTM)49.70M
Analysts70
Price Target115.76 (13.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.04%
Yearly Dividend0.32
Dividend Growth(5Y)-13.72%
DP154.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.34%
PT rev (3m)2.06%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 509.5
Fwd PE N/A
P/S 61
P/FCF 214.55
P/OCF 211.38
P/B 15.69
P/tB 16.56
EV/EBITDA 110.08
EPS(TTM)0.2
EY0.2%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.47
FCFY0.47%
OCF(TTM)0.48
OCFY0.47%
SpS1.67
BVpS6.49
TBVpS6.15
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.41
Profitability
Industry RankSector Rank
ROA 0.82%
ROE 3.06%
ROCE 4.73%
ROIC 3.41%
ROICexc 3.46%
ROICexgc 3.52%
OM 61.05%
PM (TTM) 11.9%
GM 74.32%
FCFM 28.43%
ROA(3y)-2.92%
ROA(5y)0.56%
ROE(3y)-11.33%
ROE(5y)0.68%
ROIC(3y)3.39%
ROIC(5y)3.39%
ROICexc(3y)3.42%
ROICexc(5y)3.44%
ROICexgc(3y)3.49%
ROICexgc(5y)3.51%
ROCE(3y)4.7%
ROCE(5y)4.71%
ROICexgc growth 3Y5.86%
ROICexgc growth 5Y0.71%
ROICexc growth 3Y6.01%
ROICexc growth 5Y0.84%
OM growth 3Y-1.83%
OM growth 5Y-2.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.75%
GM growth 5Y-0.16%
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF 24.51
Debt/EBITDA 9.29
Cap/Depr 80.78%
Cap/Sales 0.43%
Interest Coverage 1.76
Cash Conversion 46.86%
Profit Quality 238.9%
Current Ratio 0.16
Quick Ratio 0.16
Altman-Z 3.4
F-Score5
WACC7.31%
ROIC/WACC0.47
Cap/Depr(3y)24.87%
Cap/Depr(5y)24.57%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)109.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.53%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-32.34%
Revenue growth 3Y7.27%
Revenue growth 5Y4.78%
Sales Q2Q%-2.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35%
EBIT growth 3Y5.3%
EBIT growth 5Y2.61%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-13.08%
FCF growth 3Y-11.68%
FCF growth 5Y-7.73%
OCF growth 1Y-11.91%
OCF growth 3Y-11.5%
OCF growth 5Y-7.59%

NORTHWEST HEALTHCARE PRO / NWH-DB-H.CA FAQ

What does NORTHWEST HEALTHCARE PRO do?

Northwest Healthcare Properties Real Estate Investment Trust engages in the provision of access to a portfolio of international healthcare real estate infrastructure to investors. The company is headquartered in Toronto, Ontario. The company went IPO on 2010-03-23. The company is a global investor and operator of healthcare infrastructure assets. The company provides investors with access to a portfolio of international healthcare real estate infrastructure of interest in a diversified portfolio of about 168 income-producing properties and 15.8 million square feet of gross leasable area located throughout major markets in North America, Australasia, Brazil, and Europe. The REIT's portfolio of medical office buildings, clinics, and hospitals is characterized by long-term indexed leases and stable occupancies. The company leverages its global workforce in eight countries to serve as a long-term real estate partner to healthcare operators. The company owns, manages, acquires, and develops healthcare assets in and around key healthcare locations and clusters of outpatient facilities in urban locations in major cities.


What is the current price of NWH-DB-H stock?

The current stock price of NWH-DB-H.CA is 101.9 CAD. The price increased by 0.46% in the last trading session.


What is the ChartMill rating of NORTHWEST HEALTHCARE PRO stock?

NWH-DB-H.CA has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Would investing in NORTHWEST HEALTHCARE PRO be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NWH-DB-H.CA.